Does AXITINIB Cause Product dose omission in error? 81 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 81 reports of Product dose omission in error have been filed in association with AXITINIB (INLYTA). This represents 0.5% of all adverse event reports for AXITINIB.
81
Reports of Product dose omission in error with AXITINIB
0.5%
of all AXITINIB reports
3
Deaths
11
Hospitalizations
How Dangerous Is Product dose omission in error From AXITINIB?
Of the 81 reports, 3 (3.7%) resulted in death, 11 (13.6%) required hospitalization, and 1 (1.2%) were considered life-threatening.
Is Product dose omission in error Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AXITINIB. However, 81 reports have been filed with the FAERS database.
What Other Side Effects Does AXITINIB Cause?
Death (2,222)
Diarrhoea (2,187)
Fatigue (1,816)
Neoplasm progression (1,315)
Hypertension (1,146)
Off label use (1,075)
Nausea (955)
Decreased appetite (920)
Dysphonia (871)
Disease progression (768)
What Other Drugs Cause Product dose omission in error?
DUPILUMAB (7,586)
TOFACITINIB (2,461)
LENALIDOMIDE (618)
PALBOCICLIB (592)
DIROXIMEL (481)
ABALOPARATIDE (457)
NIRAPARIB (428)
RUXOLITINIB (425)
TERIFLUNOMIDE (371)
DIMETHYL (308)
Which AXITINIB Alternatives Have Lower Product dose omission in error Risk?
AXITINIB vs AZACITIDINE
AXITINIB vs AZATHIOPRINE
AXITINIB vs AZD-1222
AXITINIB vs AZELAIC ACID
AXITINIB vs AZELASTINE